Back to top

CytomX Therapeutics (CTMX) Gets a Buy from J.P. Morgan

J.P. Morgan analyst Anupam Rama maintained a Buy rating on CytomX Therapeutics today and set a price target of $11.00. Rama covers the Healthcare s...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CytomX Therapeutics, Inc. (CTMX)